About this medicine
- Approved name
- Adjusol trimethoprim sulfa liquide and its associated names
About this procedure
- Current status
- European Commission final decision
- Reference number
- EMEA/V/A/134
- Type
- Article 34
Divergent decision referral: initiated in order to obtain harmonisation within the EU of the conditions of authorisation for products already authorised by Member States.
- Authorisation model
- Nationally authorised product(s)
Key dates and outcomes
- Opinion date
- 10/12/2020
- EC decision date
- 25/02/2021